GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
Taiwan
· Delayed Price · Currency is TWD 41.00
+1.00 (2.50%)
Mar 10, 2026, 10:38 AM CST
GeneFerm Biotechnology Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,658 | 2,000 | 1,949 | 3,089 | 2,774 | 1,809 | Upgrade
|
| Market Cap Growth | -6.54% | 2.66% | -36.91% | 11.36% | 53.33% | 122.87% | Upgrade
|
| Enterprise Value | 1,702 | 2,053 | 2,085 | 3,172 | 2,842 | 1,711 | Upgrade
|
| Last Close Price | 40.00 | 48.25 | 47.00 | 72.17 | 63.90 | 41.33 | Upgrade
|
| PE Ratio | 57.14 | 69.31 | - | 24.79 | 29.68 | 31.51 | Upgrade
|
| PS Ratio | 2.45 | 2.95 | 3.74 | 3.89 | 4.38 | 3.46 | Upgrade
|
| PB Ratio | 2.03 | 2.45 | 2.47 | 3.46 | 3.34 | 2.42 | Upgrade
|
| P/TBV Ratio | 2.03 | 2.45 | 2.48 | 3.47 | 3.34 | 2.42 | Upgrade
|
| P/FCF Ratio | 21.85 | 26.36 | - | 25.66 | - | - | Upgrade
|
| P/OCF Ratio | 16.70 | 20.14 | 240.87 | 16.23 | 22.65 | 16.12 | Upgrade
|
| EV/Sales Ratio | 2.51 | 3.03 | 4.00 | 4.00 | 4.48 | 3.28 | Upgrade
|
| EV/EBITDA Ratio | 14.12 | 17.03 | 55.02 | 14.46 | 19.58 | 14.53 | Upgrade
|
| EV/EBIT Ratio | 36.95 | 44.55 | - | 20.66 | 27.86 | 21.70 | Upgrade
|
| EV/FCF Ratio | 22.43 | 27.05 | - | 26.35 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.40 | 0.40 | 0.30 | 0.14 | 0.22 | 0.59 | Upgrade
|
| Debt / EBITDA Ratio | 2.69 | 2.69 | 5.23 | 0.56 | 1.19 | 3.52 | Upgrade
|
| Debt / FCF Ratio | 4.27 | 4.27 | - | 1.06 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.05 | 0.05 | 0.14 | 0.01 | 0.10 | -0.14 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.37 | 0.37 | 2.97 | 0.03 | 0.55 | -0.87 | Upgrade
|
| Net Debt / FCF Ratio | 0.58 | 0.58 | -7.86 | 0.06 | -0.52 | 3.14 | Upgrade
|
| Asset Turnover | 0.56 | 0.56 | 0.45 | 0.67 | 0.51 | 0.45 | Upgrade
|
| Inventory Turnover | 2.73 | 2.73 | 2.64 | 3.41 | 3.20 | 2.94 | Upgrade
|
| Quick Ratio | 2.48 | 2.48 | 1.78 | 1.25 | 0.93 | 1.50 | Upgrade
|
| Current Ratio | 3.75 | 3.75 | 3.07 | 2.09 | 1.56 | 1.78 | Upgrade
|
| Return on Equity (ROE) | 3.60% | 3.60% | -2.68% | 14.46% | 11.84% | 10.04% | Upgrade
|
| Return on Assets (ROA) | 2.37% | 2.37% | -1.85% | 8.12% | 5.09% | 4.29% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.47% | 4.35% | -3.82% | 13.77% | 11.11% | 10.78% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.10% | 4.10% | -3.40% | 15.60% | 10.70% | 8.90% | Upgrade
|
| Earnings Yield | 1.74% | 1.44% | -1.16% | 4.04% | 3.37% | 3.17% | Upgrade
|
| FCF Yield | 4.58% | 3.79% | -0.73% | 3.90% | -5.62% | -1.80% | Upgrade
|
| Dividend Yield | - | - | - | 2.77% | 2.35% | 2.42% | Upgrade
|
| Payout Ratio | - | - | - | 49.90% | 44.36% | 5.90% | Upgrade
|
| Buyback Yield / Dilution | 0.55% | 0.55% | 0.36% | 2.26% | 8.00% | -65.83% | Upgrade
|
| Total Shareholder Return | 0.55% | 0.55% | 0.36% | 5.04% | 10.35% | -63.41% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.